Reason for request
Inclusion on the list of medicines refundable by National Health Insurance and approved for hospital use.
Clinical Benefit
| Low |
The actual benefit of BRONCHITOL is low. |
Clinical Added Value
| no clinical added value |
BRONCHITOL does not offer any improvement in actual benefit (IAB V) in the management of adult patients aged 18 and over with cystic fibrosis. |
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
QjeCtsujCRnWyRFE
Listen
